Rs 91 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Debiliptin M Tablet combines Metformin (500 mg) and Teneligliptin (20 mg) to effectively manage type 2 diabetes mellitus. Metformin works by enhancing the body's sensitivity to insulin and decreasing hepatic glucose production, while Teneligliptin inhibits the enzyme DPP-4, leading to increased insulin secretion. This dual-action helps maintain better blood glucose control. The medication is typically taken once daily with meals to minimize gastrointestinal side effects. Common side effects include hypoglycemia, nausea, vomiting, flatulence, diarrhea, constipation, headache, and dizziness. It is not recommended for patients with severe kidney, liver, or heart issues and should be used cautiously in pregnant or breastfeeding women.
Active Ingredients: Metformin (500 mg) and Teneligliptin (20 mg). Treats Type 2 Diabetes: Helps manage blood glucose levels in patients with type 2 diabetes mellitus. Mechanism of Action: Metformin enhances insulin sensitivity and reduces glucose production; Teneligliptin increases insulin secretion by inhibiting DPP-4. Common Side Effects: Hypoglycemia, nausea, vomiting, flatulence, diarrhea, constipation, headache, and dizziness. Precautions: Not recommended for patients with severe kidney, liver, or heart problems; caution advised for pregnant or breastfeeding women.
DEBILIPTIN M TABLET is an antidiabetic medication that combines two ingredients: metformin and teneligliptin. Metformin increases the body's sensitivity to insulin, a hormone crucial for glucose metabolism, helping cells use more of the blood glucose circulating in the body. It also reduces glucose production by the liver and lowers its absorption. Teneligliptin works by inhibiting the enzyme dipeptidyl peptidase (DPP)-4, which normally reduces insulin secretion. Together, these components help regulate blood sugar levels and enhance glycemic control in patients with type II diabetes.
Take DEBILIPTIN M TABLET preferably after meals, or as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dosage and length of treatment based on your age, body weight, and medical condition. Do not discontinue DEBILIPTIN M TABLET without your doctor’s advice.
PREGNANCY MONITORING REQUIRED:DEBILIPTIN M TABLET should be used during pregnancy only if absolutely necessary and prescribed by your physician. Your doctor will determine if the benefits outweigh any potential risks to the fetus. Be sure to inform your doctor before taking this medication. BREASTFEEDING NOT RECOMMENDED:DEBILIPTIN M TABLET is not advised for breastfeeding women. Consult your doctor before using this medication. DRIVING AND USING MACHINERY USE WITH CAUTION:Avoid driving or operating machinery if you experience dizziness after taking DEBILIPTIN M TABLET. ALCOHOL CONSULT YOUR DOCTOR:Refrain from drinking alcohol while taking DEBILIPTIN M TABLET, as it may increase the risk of adverse side effects. Consult your doctor for guidance. KIDNEY NOT RECOMMENDED:DEBILIPTIN M TABLET is contraindicated for individuals with severely impaired kidney function. Consult your doctor before use. LIVER CONSULT YOUR DOCTOR:Use DEBILIPTIN M TABLET with caution in patients with liver problems, especially severe conditions or gallstones. Consult your doctor before use. ALLERGY CONTRAINDICATED:Do not take DEBILIPTIN M TABLET if you are allergic to Metformin or Teneligliptin. LUNGS NOT RECOMMENDED:DEBILIPTIN M TABLET is not advised for individuals with severe lung or respiratory infections. Consult your doctor before taking it. HEART DISEASE NOT RECOMMENDED:DEBILIPTIN M TABLET is contraindicated for patients with severe heart conditions, including acute heart failure, recent heart attacks, arrhythmias, or prolonged QT intervals. Consult your doctor before use. PEDIATRICS CONSULT YOUR DOCTOR:The safety and effectiveness of DEBILIPTIN M TABLET have not been established in individuals under 18 years of age. Consult your doctor before giving this medication to children or adolescents. GERIATRICS CONSULT YOUR DOCTOR:The safety and effectiveness of DEBILIPTIN M TABLET have not been established in patients aged 65 years or older. Consult your doctor before use in elderly patients.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s